{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:45:03Z","timestamp":1767962703939,"version":"3.49.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s10822-011-9425-1","type":"journal-article","created":{"date-parts":[[2011,4,12]],"date-time":"2011-04-12T13:59:40Z","timestamp":1302616780000},"page":"349-369","source":"Crossref","is-referenced-by-count":29,"title":["Docking and quantitative structure\u2013activity relationship studies for 3-fluoro-4-(pyrrolo[2,1-f][1,2,4]triazin-4-yloxy)aniline, 3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)aniline, and 4-(4-amino-2-fluorophenoxy)-2-pyridinylamine derivatives as c-Met kinase inhibitors"],"prefix":"10.1007","volume":"25","author":[{"given":"Julio","family":"Caballero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Quiliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jans H.","family":"Alzate-Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirko","family":"Zimic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Deharo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,4,13]]},"reference":[{"issue":"7","key":"9425_CR1","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1517\/13543784.17.7.997","volume":"17","author":"X Liu","year":"2008","unstructured":"Liu X, Yao W, Newton RC, Scherle PA (2008) Targeting the c-MET signaling pathway for cancer therapy. Expert Opin Investig Drugs 17(7):997\u20131011","journal-title":"Expert Opin Investig Drugs"},{"issue":"12","key":"9425_CR2","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1158\/1078-0432.CCR-06-0818","volume":"12","author":"B Peruzzi","year":"2006","unstructured":"Peruzzi B, Bottaro DP (2006) Targeting the c-Met signaling pathway in cancer. Clin Cancer Res 12(12):3657\u20133660","journal-title":"Clin Cancer Res"},{"issue":"13","key":"9425_CR3","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1073\/pnas.0306068101","volume":"101","author":"C-G Huh","year":"2004","unstructured":"Huh C-G, Factor VM, S\u00e1nchez A, Uchida K, Conner EA, Thorgeirsson SS (2004) Hepatocyte growth factor\/c-met signaling pathway is required for efficient liver regeneration and repair. Proc Natl Acad Sci USA 101(13):4477\u20134482","journal-title":"Proc Natl Acad Sci USA"},{"issue":"13","key":"9425_CR4","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.2741\/2760","volume":"13","author":"E Lesko","year":"2008","unstructured":"Lesko E, Majka M (2008) The biological role of HGF-MET axis in tumor growth and development of metastasis. Front Biosci 13(13):1271\u20131280","journal-title":"Front Biosci"},{"issue":"6","key":"9425_CR5","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nrd2530","volume":"7","author":"PM Comoglio","year":"2008","unstructured":"Comoglio PM, Giordano S, Trusolino L (2008) Drug development of MET inhibitors: targeting oncogene addiction and expedience. Nat Rev Drug Discov 7(6):504\u2013516","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"9425_CR6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1517\/13543770903514137","volume":"20","author":"J Porter","year":"2010","unstructured":"Porter J (2010) Small molecule c-Met kinase inhibitors: a review of recent patents. Expert Opin Ther Pat 20(2):159\u2013177","journal-title":"Expert Opin Ther Pat"},{"issue":"7","key":"9425_CR7","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1158\/1078-0432.CCR-08-1306","volume":"15","author":"JP Eder","year":"2009","unstructured":"Eder JP, Vande Woude GF, Boerner SA, LoRusso PM (2009) Novel therapeutic inhibitors of the c-Met signaling pathway in cancer. Clin Cancer Res 15(7):2207\u20132214","journal-title":"Clin Cancer Res"},{"issue":"6","key":"9425_CR8","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.bmcl.2008.01.121","volume":"18","author":"GM Schroeder","year":"2008","unstructured":"Schroeder GM, Chen X-T, Williams DK, Nirschl DS, Cai Z-W, Wei D, Tokarski JS, An Y, Sack J et al (2008) Identification of pyrrolo[2, 1-f][1, 2, 4]triazine-based inhibitors of Met kinase. Bioorg Med Chem Lett 18(6):1945\u20131951","journal-title":"Bioorg Med Chem Lett"},{"issue":"17","key":"9425_CR9","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1021\/jm800476q","volume":"51","author":"KS Kim","year":"2008","unstructured":"Kim KS, Zhang L, Schmidt R, Cai Z-W, Wei D, Williams DK, Lombardo LJ, Trainor GL, Xie D et al (2008) Discovery of pyrrolopyridine\u2013pyridone based inhibitors of met kinase: synthesis, X-ray crystallographic analysis, and biological activities. J Med Chem 51(17):5330\u20135341","journal-title":"J Med Chem"},{"issue":"9","key":"9425_CR10","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1016\/j.bmcl.2010.01.042","volume":"20","author":"DK Williams","year":"2010","unstructured":"Williams DK, Chen X-T, Tarby C, Kaltenbach R, Cai Z-W, Tokarski JS, An Y, Sack JS, Wautlet B et al (2010) Design, synthesis and structure-activity relationships of novel biarylamine-based Met kinase inhibitors. Bioorg Med Chem Lett 20(9):2998\u20133002","journal-title":"Bioorg Med Chem Lett"},{"issue":"11","key":"9425_CR11","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1016\/j.bmcl.2008.04.047","volume":"18","author":"Z-W Cai","year":"2008","unstructured":"Cai Z-W, Wei D, Schroeder GM, Cornelius LAM, Kim K, Chen X-T, Schmidt RJ, Williams DK, Tokarski JS et al (2008) Discovery of orally active pyrrolopyridine- and aminopyridine-based Met kinase inhibitors. Bioorg Med Chem Lett 18(11):3224\u20133229","journal-title":"Bioorg Med Chem Lett"},{"issue":"5","key":"9425_CR12","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1021\/jm801586s","volume":"52","author":"GM Schroeder","year":"2009","unstructured":"Schroeder GM, An Y, Cai Z-W, Chen X-T, Clark C, Cornelius LAM, Dai J, Gullo-Brown J, Gupta A et al (2009) Discovery of N-(4-(2-Amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1, 2-dihydropyridine-3-carboxamide (BMS-777607), a selective and orally efficacious inhibitor of the met kinase superfamily. J Med Chem 52(5):1251\u20131254","journal-title":"J Med Chem"},{"issue":"10","key":"9425_CR13","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1021\/jm800043g","volume":"51","author":"BK Albrecht","year":"2008","unstructured":"Albrecht BK, Harmange J-C, Bauer D, Berry L, Bode C, Boezio AA, Chen A, Choquette D, Dussault I et al (2008) Discovery and optimization of triazolopyridazines as potent and selective inhibitors of the c-Met Kinase\u2020. J Med Chem 51(10):2879\u20132882","journal-title":"J Med Chem"},{"issue":"22","key":"9425_CR14","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1016\/j.bmcl.2009.09.096","volume":"19","author":"AA Boezio","year":"2009","unstructured":"Boezio AA, Berry L, Albrecht BK, Bauer D, Bellon SF, Bode C, Chen A, Choquette D, Dussault I et al (2009) Discovery and optimization of potent and selective triazolopyridazine series of c-Met inhibitors. Bioorg Med Chem Lett 19(22):6307\u20136312","journal-title":"Bioorg Med Chem Lett"},{"issue":"18","key":"9425_CR15","doi-asserted-by":"crossref","first-page":"5766","DOI":"10.1021\/jm8006189","volume":"51","author":"ND D\u2019Angelo","year":"2008","unstructured":"D\u2019Angelo ND, Bellon SF, Booker SK, Cheng Y, Coxon A, Dominguez C, Fellows I, Hoffman D, Hungate R et al (2008) Design, synthesis, and biological evaluation of potent c-Met inhibitors. J Med Chem 51(18):5766\u20135779","journal-title":"J Med Chem"},{"issue":"2","key":"9425_CR16","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.bmcl.2008.11.062","volume":"19","author":"J Porter","year":"2009","unstructured":"Porter J, Lumb S, Lecomte F, Reuberson J, Foley A, Calmiano M, le Riche K, Edwards H, Delgado J et al (2009) Discovery of a novel series of quinoxalines as inhibitors of c-Met kinase. Bioorg Med Chem Lett 19(2):397\u2013400","journal-title":"Bioorg Med Chem Lett"},{"issue":"10","key":"9425_CR17","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1016\/j.bmcl.2009.03.110","volume":"19","author":"J Porter","year":"2009","unstructured":"Porter J, Lumb S, Franklin RJ, Gascon-Simorte JM, Calmiano M, Riche KL, Lallemand B, Keyaerts J, Edwards H et al (2009) Discovery of 4-azaindoles as novel inhibitors of c-Met kinase. Bioorg Med Chem Lett 19(10):2780\u20132784","journal-title":"Bioorg Med Chem Lett"},{"issue":"4","key":"9425_CR18","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1021\/ci8004034","volume":"49","author":"JH Alzate-Morales","year":"2009","unstructured":"Alzate-Morales JH, Caballero J, Vergara-Jaque A, Gonz\u00e1lez-Nilo FD (2009) Insights into the structural basis of N2 and O6 substituted guanine derivatives as cyclin-dependent kinase 2 (CDK2) inhibitors: prediction of the binding modes and potency of the inhibitors by docking and ONIOM calculations. J Chem Inf Model 49(4):886\u2013899","journal-title":"J Chem Inf Model"},{"issue":"6","key":"9425_CR19","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1021\/ci100049h","volume":"50","author":"JH Alzate-Morales","year":"2010","unstructured":"Alzate-Morales JH, Vergara-Jaque A, Caballero J (2010) Computational study on the interaction of N1 substituted pyrazole derivatives with B-Raf kinase: an unusual water wire hydrogen-bond network and novel interactions at the entrance of the active site. J Chem Inf Model 50(6):1101\u20131112","journal-title":"J Chem Inf Model"},{"issue":"21","key":"9425_CR20","doi-asserted-by":"crossref","first-page":"6543","DOI":"10.1021\/jm901330e","volume":"52","author":"CA Larsen","year":"2009","unstructured":"Larsen CA, Bisson WH, Dashwood RH (2009) Tea catechins inhibit hepatocyte growth factor receptor (MET Kinase) activity in human colon cancer cells: kinetic and molecular docking studies. J Med Chem 52(21):6543\u20136545","journal-title":"J Med Chem"},{"issue":"6","key":"9425_CR21","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1021\/ci050263i","volume":"45","author":"M Fernandez","year":"2005","unstructured":"Fernandez M, Tundidor-Camba A, Caballero J (2005) Modeling of cyclin-dependent kinase inhibition by 1H-Pyrazolo[3, 4-d]Pyrimidine derivatives using artificial neural network ensembles. J Chem Inf Model 45(6):1884\u20131895","journal-title":"J Chem Inf Model"},{"issue":"4","key":"9425_CR22","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s11538-005-9006-3","volume":"68","author":"M Gonz\u00e1lez","year":"2006","unstructured":"Gonz\u00e1lez M, Caballero J, Helguera A, Garriga M, Gonz\u00e1lez G, Fern\u00e1ndez M (2006) 2D autocorrelation modelling of the inhibitory activity of cytokinin-derived cyclin-dependent kinase inhibitors. Bull Math Biol 68(4):735\u2013751","journal-title":"Bull Math Biol"},{"issue":"2","key":"9425_CR23","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.bmc.2007.10.024","volume":"16","author":"J Caballero","year":"2008","unstructured":"Caballero J, Fern\u00e1ndez M, Saavedra M, Gonz\u00e1lez-Nilo FD (2008) 2D Autocorrelation, CoMFA, and CoMSIA modeling of protein tyrosine kinases\u2019 inhibition by substituted pyrido[2, 3-d]pyrimidine derivatives. Bioorg Med Chem 16(2):810\u2013821","journal-title":"Bioorg Med Chem"},{"issue":"11","key":"9425_CR24","doi-asserted-by":"crossref","first-page":"6103","DOI":"10.1016\/j.bmc.2008.04.048","volume":"16","author":"J Caballero","year":"2008","unstructured":"Caballero J, Fern\u00e1ndez M, Gonz\u00e1lez-Nilo FD (2008) Structural requirements of pyrido[2, 3-d]pyrimidin-7-one as CDK4\/D inhibitors: 2D autocorrelation, CoMFA and CoMSIA analyses. Bioorg Med Chem 16(11):6103\u20136115","journal-title":"Bioorg Med Chem"},{"issue":"5","key":"9425_CR25","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1016\/j.bmc.2007.11.053","volume":"16","author":"C Gueto","year":"2008","unstructured":"Gueto C, Ruiz JL, Torres JE, M\u00e9ndez J, Vivas-Reyes R (2008) Three-dimensional quantitative structure-activity relationship studies on novel series of benzotriazine based compounds acting as Src inhibitors using CoMFA and CoMSIA. Bioorg Med Chem 16(5):2439\u20132447","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"9425_CR26","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1021\/ci900302z","volume":"50","author":"J Alzate-Morales","year":"2010","unstructured":"Alzate-Morales J, Caballero J (2010) Computational study of the interactions between guanine derivatives and cyclin-dependent kinase 2 (CDK2) by CoMFA and QM\/MM. J Chem Inf Model 50(1):110\u2013122","journal-title":"J Chem Inf Model"},{"issue":"8","key":"9425_CR27","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.jmgm.2007.11.005","volume":"26","author":"D Muthas","year":"2008","unstructured":"Muthas D, Sabnis YA, Lundborg M, Karl\u00e9n A (2008) Is it possible to increase hit rates in structure-based virtual screening by pharmacophore filtering? An investigation of the advantages and pitfalls of post-filtering. J Mol Graph Model 26(8):1237\u20131251","journal-title":"J Mol Graph Model"},{"issue":"7","key":"9425_CR28","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1016\/j.bmcl.2009.02.049","volume":"19","author":"H-Z Xie","year":"2009","unstructured":"Xie H-Z, Li L-L, Ren J-X, Zou J, Yang L, Wei Y-Q, Yang S-Y (2009) Pharmacophore modeling study based on known spleen tyrosine kinase inhibitors together with virtual screening for identifying novel inhibitors. Bioorg Med Chem Lett 19(7):1944\u20131949","journal-title":"Bioorg Med Chem Lett"},{"issue":"6","key":"9425_CR29","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1039\/b719959g","volume":"6","author":"M Uno","year":"2008","unstructured":"Uno M, Ban HS, Nabeyama W, Nakamura H (2008) de novo design and synthesis of N-benzylanilines as new candidates for VEGFR tyrosine kinase inhibitors. Org Biomol Chem 6(6):979\u2013981","journal-title":"Org Biomol Chem"},{"issue":"20","key":"9425_CR30","doi-asserted-by":"crossref","first-page":"6456","DOI":"10.1021\/jm901147e","volume":"52","author":"M Vieth","year":"2009","unstructured":"Vieth M, Erickson J, Wang J, Webster Y, Mader M, Higgs R, Watson I (2009) Kinase inhibitor data modeling and de novo inhibitor design with fragment approaches. J Med Chem 52(20):6456\u20136466","journal-title":"J Med Chem"},{"issue":"2","key":"9425_CR31","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1529\/biophysj.106.091512","volume":"92","author":"JH Alzate-Morales","year":"2007","unstructured":"Alzate-Morales JH, Contreras R, Soriano A, Tu\u00f1on I, Silla E (2007) A computational study of the protein-ligand interactions in CDK2 inhibitors: using quantum mechanics\/molecular mechanics interaction energy as a predictor of the biological activity. Biophys J 92(2):430\u2013439","journal-title":"Biophys J"},{"issue":"1\u20133","key":"9425_CR32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cplett.2009.08.020","volume":"479","author":"JH Alzate-Morales","year":"2009","unstructured":"Alzate-Morales JH, Caballero J, Gonzalez-Nilo FD, Contreras R (2009) A computational ONIOM model for the description of the H-bond interactions between NU2058 analogues and CDK2 active site. Chem Phys Lett 479(1\u20133):149\u2013155","journal-title":"Chem Phys Lett"},{"key":"9425_CR33","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/07391102.2002.10506853","volume":"20","author":"O Villaca\u00f1as","year":"2002","unstructured":"Villaca\u00f1as O, P\u00e9rez JJ, Rubio-Mart\u00ednez J (2002) Structural analysis of the inhibition of Cdk4 and Cdk6 by p16INK4a through molecular dynamics simulations. J Biomol Struct Dyn 20:347\u2013358","journal-title":"J Biomol Struct Dyn"},{"issue":"6","key":"9425_CR34","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1747-0285.2009.00895.x","volume":"74","author":"Y Asses","year":"2009","unstructured":"Asses Y, Leroux V, Tairi-Kellou S, Dono R, Maina F, Maigret B (2009) Analysis of c-Met kinase domain complexes: a new specific catalytic site receptor model for defining binding modes of ATP-competitive ligands. Chem Biol Drug Des 74(6):560\u2013570","journal-title":"Chem Biol Drug Des"},{"issue":"24","key":"9425_CR35","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1021\/jm00050a010","volume":"37","author":"G Klebe","year":"1994","unstructured":"Klebe G, Abraham U, Mietzner T (1994) Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J Med Chem 37(24):4130\u20134146","journal-title":"J Med Chem"},{"issue":"23","key":"9425_CR36","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1021\/jm0309194","volume":"46","author":"B Wellenzohn","year":"2003","unstructured":"Wellenzohn B, Liedl KR, Rode BM, Zaheer-ul-haq (2003) Molecular docking studies of natural cholinesterase-inhibiting steroidal alkaloids from sarcococca saligna. J Med Chem 46(23):5087\u20135090","journal-title":"J Med Chem"},{"issue":"2","key":"9425_CR37","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3233\/JAD-2010-1262","volume":"19","author":"LE Rojo","year":"2010","unstructured":"Rojo LE, Alzate-Morales J, Saavedra IN, Davies P, Maccioni RB (2010) Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of alzheimer\u2019s disease. J Alzheimer Dis 19(2):573\u2013589","journal-title":"J Alzheimer Dis"},{"issue":"10","key":"9425_CR38","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1023\/A:1014356529909","volume":"15","author":"S Hanessian","year":"2001","unstructured":"Hanessian S, Moitessier N, Therrien E (2001) A comparative docking study and the design of potentially selective MMP inhibitors. J Comput Aided Mol Des 15(10):873\u2013881","journal-title":"J Comput Aided Mol Des"},{"issue":"4","key":"9425_CR39","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s11030-009-9140-1","volume":"13","author":"J Caballero","year":"2009","unstructured":"Caballero J, Vergara-Jaque A, Fern\u00e1ndez M, Coll D (2009) Docking and quantitative structure\u2013activity relationship studies for sulfonyl hydrazides as inhibitors of cytosolic human branched-chain amino acid aminotransferase. Mol Divers 13(4):493\u2013500","journal-title":"Mol Divers"},{"issue":"5","key":"9425_CR40","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1747-0285.2008.00716.x","volume":"72","author":"CF Lagos","year":"2008","unstructured":"Lagos CF, Caballero J, Gonzalez-Nilo FD, David Pessoa-Mahana C, Perez-Acle T (2008) Docking and quantitative structure-activity relationship studies for the bisphenylbenzimidazole family of non-nucleoside inhibitors of HIV-1 reverse transcriptase. Chem Biol Drug Des 72(5):360\u2013369","journal-title":"Chem Biol Drug Des"},{"issue":"5","key":"9425_CR41","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/jcc.540150503","volume":"15","author":"R Abagyan","year":"1994","unstructured":"Abagyan R, Totrov M, Kuznetsov D (1994) ICM\u2013A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation. J Comput Chem 15(5):488\u2013506","journal-title":"J Comput Chem"},{"key":"9425_CR42","unstructured":"Molecular Editor, version 2.5, La Jolla, CA, Molsoft LLC, 2006"},{"key":"9425_CR43","unstructured":"ICM, version 3.4-8, La Jolla, CA, Molsoft LLC, 2006"},{"issue":"6","key":"9425_CR44","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1074\/mcp.M400159-MCP200","volume":"4","author":"J An","year":"2005","unstructured":"An J, Totrov M, Abagyan R (2005) Pocketome via comprehensive identification and classification of ligand binding envelopes. Mol Cell Proteomics 4(6):752\u2013761","journal-title":"Mol Cell Proteomics"},{"issue":"18","key":"9425_CR45","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.2174\/156802608786786570","volume":"8","author":"J Caballero","year":"2008","unstructured":"Caballero J, Fern\u00e1ndez M (2008) Artificial neural networks from MATLAB in medicinal chemistry. Bayesian-regularized genetic neural networks (BRGNN): application to the prediction of the antagonistic activity against human platelet thrombin receptor (PAR-1). Curr Top Med Chem 8(18):1580\u20131605","journal-title":"Curr Top Med Chem"},{"key":"9425_CR46","unstructured":"DRAGON, version 3.0, Milano, Italy, Milano Chemometrics, 2003"},{"issue":"3","key":"9425_CR47","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1021\/ci015504a","volume":"42","author":"V Consonni","year":"2002","unstructured":"Consonni V, Todeschini R, Pavan M (2002) Structure\/response correlations and similarity\/diversity analysis by GETAWAY descriptors. 1. Theory of the novel 3D molecular descriptors. J Chem Inf Comput Sci 42(3):682\u2013692","journal-title":"J Chem Inf Comput Sci"},{"issue":"18","key":"9425_CR48","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.1016\/j.bmc.2007.06.014","volume":"15","author":"M Fern\u00e1ndez","year":"2007","unstructured":"Fern\u00e1ndez M, Caballero J (2007) QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-[alpha]-phenylsulfonylacetamide derivatives. Bioorg Med Chem 15(18):6298\u20136310","journal-title":"Bioorg Med Chem"},{"issue":"3","key":"9425_CR49","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1021\/ci00063a006","volume":"29","author":"VN Viswanadhan","year":"1989","unstructured":"Viswanadhan VN, Ghose AK, Revankar GR, Robins RK (1989) Atomic physicochemical parameters for three dimensional structure directed quantitative structure-activity relationships. 4. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of certain naturally occurring nucleoside antibiotics. J Chem Inf Comput Sci 29(3):163\u2013172","journal-title":"J Chem Inf Comput Sci"},{"issue":"20","key":"9425_CR50","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1021\/jm000942e","volume":"43","author":"P Ertl","year":"2000","unstructured":"Ertl P, Rohde B, Selzer P (2000) Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem 43(20):3714\u20133717","journal-title":"J Med Chem"},{"key":"9425_CR51","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1248\/cpb.40.127","volume":"40","author":"I Miroguchi","year":"1992","unstructured":"Miroguchi I, Hirono S, Liu Q, Nakagome I, Matsushita Y (1992) Simple method of calculating octanol\/water partition coefficient. Chem Pharm Bull 40:127\u2013130","journal-title":"Chem Pharm Bull"},{"issue":"6","key":"9425_CR52","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1521-3838(200012)19:6<599::AID-QSAR599>3.0.CO;2-B","volume":"19","author":"DB Oliveira de","year":"2000","unstructured":"de Oliveira DB, Gaudio AC (2000) BuildQSAR: a new computer program for QSAR analysis. Quant Struct Act Relat 19(6):599\u2013601","journal-title":"Quant Struct Act Relat"},{"issue":"1\u20132","key":"9425_CR53","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0166-1280(02)00616-4","volume":"622","author":"MTD Cronin","year":"2003","unstructured":"Cronin MTD, Schultz TW (2003) Pitfalls in QSAR. J Mol Struct 622(1\u20132):39\u201351","journal-title":"J Mol Struct"},{"issue":"6","key":"9425_CR54","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1080\/14756360600862366","volume":"21","author":"M Fernandez","year":"2006","unstructured":"Fernandez M, Carreiras MC, Marco JL, Caballero J (2006) Modeling of acetylcholinesterase inhibition by tacrine analogues using Bayesian-regularized Genetic Neural Networks and ensemble averaging. J Enzyme Inhib Med Chem 21(6):647\u2013661","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"24","key":"9425_CR55","doi-asserted-by":"crossref","first-page":"7746","DOI":"10.1016\/j.bmc.2007.08.057","volume":"15","author":"MH Fatemi","year":"2007","unstructured":"Fatemi MH, Gharaghani S (2007) A novel QSAR model for prediction of apoptosis-inducing activity of 4-aryl-4-H-chromenes based on support vector machine. Bioorg Med Chem 15(24):7746\u20137754","journal-title":"Bioorg Med Chem"},{"issue":"11","key":"9425_CR56","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.ejmech.2005.04.014","volume":"40","author":"MP Gonz\u00e1lez","year":"2005","unstructured":"Gonz\u00e1lez MP, Ter\u00e1n C, Teijeira M, Gonz\u00e1lez-Moa MJ (2005) GETAWAY descriptors to predicting A2A adenosine receptors agonists. Eur J Med Chem 40(11):1080\u20131086","journal-title":"Eur J Med Chem"},{"issue":"4","key":"9425_CR57","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1093-3263(01)00123-1","volume":"20","author":"A Golbraikh","year":"2002","unstructured":"Golbraikh A, Tropsha A (2002) Beware of q2!. J Mol Graph Model 20(4):269\u2013276","journal-title":"J Mol Graph Model"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-011-9425-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10822-011-9425-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-011-9425-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T23:48:44Z","timestamp":1560124124000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10822-011-9425-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["9425"],"URL":"https:\/\/doi.org\/10.1007\/s10822-011-9425-1","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}